calendar
61 catalysts · 15 phase 2 initiation · 13 phase 2 completion · 6 phase 1 completion · 4 phase 1 initiation · 4 phase 3 initiation · 4 phase 1 2 initiation
next 91 dayslessmore
MonWedFri
61 catalysts · 15 phase 2 initiation · 13 phase 2 completion · 6 phase 1 completion · 4 phase 1 initiation · 4 phase 3 initiation · 4 phase 1 2 initiation
Therapy area: Oncology. Indication: Solid Tumor, Squamous Non-Small Cell Lung Cancer
Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease), Non-Hodgkin Lymphoma, Refractory Multiple Myeloma, Relapsed Multiple Myeloma
Therapy area: Oncology. Indication: Lung Cancer
Therapy area: Oncology. Indication: Blood Cancer, Hematological Tumor, Leukemia, Lymphoma
Therapy area: Oncology. Indication: Colorectal Cancer
Therapy area: Oncology. Indication: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Therapy area: Oncology. Indication: Ovarian Cancer
Therapy area: Oncology. Indication: Glioblastoma Multiforme (GBM), Recurrent Glioblastoma Multiforme (GBM)
Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease), Refractory Multiple Myeloma, Relapsed Multiple Myeloma
Therapy area: Ophthalmology. Indication: Choroidal Neovascularization, Dry (Atrophic) Macular Degeneration, Geographic Atrophy
Therapy area: Immunology. Indication: Rheumatoid Arthritis